BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
HIV infection
,
Kidney
,
Alcohol
,
Doxorubicin
,
rs7903146
,
LEP
,
Apoptosis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
FGFR1 proteins
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
L1000 CMAP - Carcinoma of prostate PC3 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
MiR-21-3p Inhibits Adipose Browning by Targeting FGFR1 and Aggravates Atrial Fibrosis in Diabetes.
FGFR1 Antibody Validation and Characterization of FGFR1 Protein Expression in ER+ Breast Cancer.
A Novel FGFR1 Missense Mutation in a Portuguese Family with Congenital Hypogonadotropic Hypogonadism…
FGF21 prevents neuronal cell ferroptosis after spinal cord injury by activating the FGFR1/β-Klotho p…
Expression and Purification of FGFR1-Fc Fusion Protein and Its Effects on Human Lung Squamous Carcin…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Rogaratinib for BCG Refractory High Risk Non-Muscle Invasive Bladder Cancer With FGFR1/2 Overexpress…
Basket Trial in Solid Tumors Harboring a Fusion of FGFR1, FGFR2 or FGFR3- (FUZE Clinical Trial)
Ponatinib for Patients Whose Advanced Solid Tumor Cancer Has Activating Mutations Involving the Foll…
Real Word European Registry of NTRK Fusions and Other Rare Actionable Fusions (TRacKING)
A Monotherapy in Subjects With Advanced Solid Tumors
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ